智通财经APP讯,嘉和生物-B(06998)发布公告,于2025年9月3日因行政总裁根据于2023年10月27日采纳的2023年受限制股份单位计划归属受限制股份单位而发行股份68.41万股;因行政总裁根据2023年购股权计划行使购股权而发行股份90.66万股;及因合资格雇员根据首次公开发售后购股权计划行使购股权而发行股份28.44万股。
智通财经APP讯,嘉和生物-B(06998)发布公告,于2025年9月3日因行政总裁根据于2023年10月27日采纳的2023年受限制股份单位计划归属受限制股份单位而发行股份68.41万股;因行政总裁根据2023年购股权计划行使购股权而发行股份90.66万股;及因合资格雇员根据首次公开发售后购股权计划行使购股权而发行股份28.44万股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.